The 20th Annual Meeting of the Oligonucleotide Therapeutics Society will be held from October 6th - 9th in Montreal, Canada. PhoenixBio is excited to be sponsoring a booth and attending the the annual meeting to get the latest updates in the fast moving field of Oligonucleotides! Meet with our team at Booth #3-1 to learn more about PhoenixBio's capabilities and how our humanized liver mouse model and fresh human hepatocytes provide an unparalleled translational platform to advance your studies.
The Annual Meeting of the Oligonucleotide Therapeutics Society (OTS) serves as a platform to advance the Society's mission and objectives, promoting research from both academic and industry perspectives focused on oligonucleotide therapeutics. This event facilitates ongoing conversations among industry professionals, academic researchers, and health authorities, aimed at educating participants and sharing advancements in the fundamental research and therapeutic applications of oligonucleotides. This includes areas such as antisense technology, siRNA, immunostimulatory approaches, aptamer use, RNA/DNA editing, and mRNA therapies, as well as foundational RNA research.